Peregrine Capital Management LLC Purchases 80,369 Shares of Ardent Health Partners, LLC (NYSE:ARDT)

Peregrine Capital Management LLC increased its stake in shares of Ardent Health Partners, LLC (NYSE:ARDT - Free Report) by 30.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 341,235 shares of the company's stock after acquiring an additional 80,369 shares during the quarter. Peregrine Capital Management LLC owned approximately 0.24% of Ardent Health Partners worth $5,828,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. R Squared Ltd bought a new stake in shares of Ardent Health Partners in the fourth quarter worth about $37,000. BNP Paribas Financial Markets bought a new stake in shares of Ardent Health Partners in the 3rd quarter worth approximately $42,000. Financial Management Professionals Inc. bought a new stake in shares of Ardent Health Partners in the 3rd quarter worth approximately $50,000. MetLife Investment Management LLC purchased a new position in shares of Ardent Health Partners during the third quarter valued at approximately $135,000. Finally, JPMorgan Chase & Co. bought a new position in shares of Ardent Health Partners during the third quarter valued at approximately $154,000.

Analyst Ratings Changes

Several analysts recently weighed in on ARDT shares. Morgan Stanley cut their price target on shares of Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating on the stock in a report on Tuesday, January 21st. Truist Financial decreased their price objective on shares of Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating for the company in a report on Monday, January 6th. Leerink Partners upped their price objective on shares of Ardent Health Partners from $23.00 to $25.00 and gave the stock an "outperform" rating in a report on Tuesday, November 12th. Bank of America cut Ardent Health Partners from a "buy" rating to a "neutral" rating and cut their price objective for the company from $22.00 to $19.00 in a research report on Wednesday, November 6th. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and set a $23.00 price objective on shares of Ardent Health Partners in a research report on Thursday, November 14th. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, Ardent Health Partners currently has an average rating of "Buy" and an average target price of $21.55.

Ardent Health Partners Stock Down 6.6 %

ARDT stock traded down $0.98 on Friday, reaching $13.86. 527,624 shares of the company traded hands, compared to its average volume of 337,948. Ardent Health Partners, LLC has a one year low of $13.63 and a one year high of $20.72. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. The firm has a fifty day simple moving average of $15.44 and a 200-day simple moving average of $16.90.

Ardent Health Partners Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.